Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

N-acetyl-l-cysteine

N De Vries1, S De Flora

  • 1Department of Otolaryngology, Free University Hospital, Amsterdam, The Netherlands.

Journal of Cellular Biochemistry. Supplement
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

N-acetyl-l-cysteine (NAC) is an antioxidant being studied as a chemopreventive agent for various cancers. Preliminary data suggest good patient compliance and a low incidence of side effects in the EUROSCAN trial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug-Induced Sleep Endoscopy in adults with Sleep Disordered Breathing: Technique and the VOTE Classification System.

Operative techniques in otolaryngology--head and neck surgery·2026
Same author

Definition of severity, management, and follow-up of isolated snoring in adults: An international consensus.

European annals of otorhinolaryngology, head and neck diseases·2026
Same author

Unique Nerve Tissue-Restricted T-Cell Clones in Chronic Inflammatory Demyelinating Polyneuropathy.

Journal of the peripheral nervous system : JPNS·2025
Same author

Predicting complete concentric collapse at the palatal level during drug-induced sleep endoscopy: an analysis of 1761 cases.

Sleep & breathing = Schlaf & Atmung·2024
Same author

Prevalence of obstructive sleep apnea after treatment for advanced T-stage head and neck cancer.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2024
Same author

Intention to leave, depersonalisation and job satisfaction in physicians and nurses: a cross-sectional study in Europe.

Scientific reports·2024

Area of Science:

  • Oncology
  • Chemoprevention
  • Antioxidant Research

Background:

  • Traditional chemopreventive agents like beta-carotene and retinoids are commonly used for oral leukoplakia, head and neck, and lung cancers.
  • N-acetyl-l-cysteine (NAC), an antioxidant, is being investigated as a novel chemopreventive agent.
  • NAC's potential benefits are supported by experimental data demonstrating protective effects against mutagens, genotoxicity, and carcinogen-DNA adduct formation.

Purpose of the Study:

  • To evaluate N-acetyl-l-cysteine (NAC) as a chemopreventive agent in cancer patients.
  • To assess the efficacy and safety of NAC in the EUROSCAN clinical trial.
  • To explore NAC's role in preventing cancer recurrence or new primary tumors.

Main Methods:

  • The EUROSCAN study, part of the European Organization for Research and Treatment of Cancer (EORTC), is investigating NAC in patients with a history of oral, laryngeal, or lung cancer.

Related Experiment Videos

  • Patients receive NAC as part of a chemoprevention strategy.
  • Data on patient compliance and the frequency of side effects are collected.

    • Main Results:

    • Preliminary results from the EUROSCAN trial indicate good patient compliance with NAC treatment.
    • The study has observed a low frequency of side effects associated with NAC administration.
    • Experimental data support NAC's protective mechanisms, including inhibition of mutagenic agents and DNA damage.

    Conclusions:

    • N-acetyl-l-cysteine (NAC) shows promise as a chemopreventive agent due to its antioxidant properties and experimental evidence.
    • The preliminary findings of the EUROSCAN trial suggest that NAC is well-tolerated and compliant in patients undergoing cancer treatment.
    • Further research and analysis of EUROSCAN data are warranted to confirm NAC's role in cancer chemoprevention.